These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 24785471)

  • 1. Fifty years of age-based screening: time for a new risk-based screening approach.
    Kerlikowske K; O'Kane ME; Esserman LJ
    Evid Based Med; 2014 Oct; 19(5):183. PubMed ID: 24785471
    [No Abstract]   [Full Text] [Related]  

  • 2. ACP Journal Club. Annual mammography screening did not reduce long-term breast cancer mortality in women 40 to 59 years of age.
    Fletcher SW
    Ann Intern Med; 2014 May; 160(10):JC7. PubMed ID: 24842441
    [No Abstract]   [Full Text] [Related]  

  • 3. Too much mammography.
    Kalager M; Adami HO; Bretthauer M
    BMJ; 2014 Feb; 348():g1403. PubMed ID: 24519765
    [No Abstract]   [Full Text] [Related]  

  • 4. Screening mammography may be less effective than thought.
    Niemczyk NA
    J Midwifery Womens Health; 2014; 59(4):465-7. PubMed ID: 25215355
    [No Abstract]   [Full Text] [Related]  

  • 5. The Canadian National Breast Screening Study: caveat emptor.
    Javitt MC
    AJR Am J Roentgenol; 2014 May; 202(5):W505. PubMed ID: 24758687
    [No Abstract]   [Full Text] [Related]  

  • 6. The authors reply.
    Miller AB; Wall C; Baines CJ; Sun P; To T; Narod SA
    Am J Epidemiol; 2014 Oct; 180(7):760-1. PubMed ID: 25194150
    [No Abstract]   [Full Text] [Related]  

  • 7. Re: "Twenty five year follow-up for breast cancer incidence and mortality of the Canadian National Breast Screening Study: randomised screening trial".
    Weiss NS
    Am J Epidemiol; 2014 Oct; 180(7):759-60. PubMed ID: 25194149
    [No Abstract]   [Full Text] [Related]  

  • 8. Getting screened? Caveat emptor.
    Baines CJ
    AJR Am J Roentgenol; 2014 Nov; 203(5):W562. PubMed ID: 25341181
    [No Abstract]   [Full Text] [Related]  

  • 9. Breast Cancer Screening and Optimizing Recommendations.
    Lancaster RB; Gulla S; De Los Santos J; Umphrey H
    Semin Roentgenol; 2018 Oct; 53(4):280-293. PubMed ID: 30449346
    [No Abstract]   [Full Text] [Related]  

  • 10. Do the benefits of screening mammography outweigh the harms of overdiagnosis and unnecessary treatment?--no.
    Bell RJ; Burton RC
    Med J Aust; 2012 Jan; 196(1):17. PubMed ID: 22256918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breast Cancer Risk Assessment Models and High-Risk Screening.
    Barke LD; Freivogel ME
    Radiol Clin North Am; 2017 May; 55(3):457-474. PubMed ID: 28411673
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The eternal problem of false positives in mammography screening].
    Seguí Díaz M
    Semergen; 2017 Mar; 43(2):151-153. PubMed ID: 27117788
    [No Abstract]   [Full Text] [Related]  

  • 13. Breast cancer screening: controversy of impact.
    Berry DA
    Breast; 2013 Aug; 22 Suppl 2(0 2):S73-6. PubMed ID: 24074796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence to Support Screening Women in Their 40s.
    Ray KM; Price ER; Joe BN
    Radiol Clin North Am; 2017 May; 55(3):429-439. PubMed ID: 28411671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening for Breast Cancer.
    Niell BL; Freer PE; Weinfurtner RJ; Arleo EK; Drukteinis JS
    Radiol Clin North Am; 2017 Nov; 55(6):1145-1162. PubMed ID: 28991557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence to Support Screening Women Annually.
    Eby PR
    Radiol Clin North Am; 2017 May; 55(3):441-456. PubMed ID: 28411672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Collaborative Modeling of the Benefits and Harms Associated With Different U.S. Breast Cancer Screening Strategies.
    Mandelblatt JS; Stout NK; Schechter CB; van den Broek JJ; Miglioretti DL; Krapcho M; Trentham-Dietz A; Munoz D; Lee SJ; Berry DA; van Ravesteyn NT; Alagoz O; Kerlikowske K; Tosteson AN; Near AM; Hoeffken A; Chang Y; Heijnsdijk EA; Chisholm G; Huang X; Huang H; Ergun MA; Gangnon R; Sprague BL; Plevritis S; Feuer E; de Koning HJ; Cronin KA
    Ann Intern Med; 2016 Feb; 164(4):215-25. PubMed ID: 26756606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Controversy surrounding mammography screening? Not in our opinion.
    Drukteinis JS; Kiluk JV
    Cancer Control; 2014 Apr; 21(2):176-7. PubMed ID: 24667405
    [No Abstract]   [Full Text] [Related]  

  • 19. Including the method of detection for breast cancer in the Surveillance, Epidemiology, and End Results database is long overdue.
    Kopans DB; Sharpe RE; Eby PR
    J Med Screen; 2024 Mar; 31(1):1-2. PubMed ID: 37624726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EMAS position statement: individualized breast cancer screening versus population-based mammography screening programmes.
    Depypere H; Desreux J; Pérez-López FR; Ceausu I; Erel CT; Lambrinoudaki I; Schenck-Gustafsson K; van der Schouw YT; Simoncini T; Tremollieres F; Rees M; EMAS
    Maturitas; 2014 Dec; 79(4):481-6. PubMed ID: 25277123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.